Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel J Rawle

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Viruses|January 21, 2023
Monoclonal Antibodies Specific for SARS-CoV-2 Spike Protein Suitable for Multiple Applications for Current Variants of ConcernMahali S Morgan, Kexin Yan, Thuy T Le, et al.
Vaccines|May 9, 2020
Arthritogenic Alphavirus Vaccines: Serogrouping Versus Cross-Protection in Mouse ModelsWilson Nguyen, Eri Nakayama, Kexin Yan, et al.
Nature Communications|June 9, 2021
A versatile reverse genetics platform for SARS-CoV-2 and other positive-strand RNA virusesAlberto A Amarilla, Julian D J Sng, Rhys Parry, et al.
ACS Central Science|June 1, 2022
Synthetic Heparan Sulfate Mimetic Pixatimod (PG545) Potently Inhibits SARS-CoV-2 by Disrupting the Spike-ACE2 InteractionScott E Guimond, Courtney J Mycroft-West, Neha S Gandhi, et al.
Journal of Virology|April 25, 2025
Twelfth scientific biennial meeting of the Australasian Virology Society: AVS12 2024Ebony A Monson, Robson K Loterio, Justin A Roby, et al.
Cell|April 3, 2021
BET inhibition blocks inflammation-induced cardiac dysfunction and SARS-CoV-2 infectionRichard J Mills, Sean J Humphrey, Patrick R J Fortuna, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Viruses|January 21, 2023
Monoclonal Antibodies Specific for SARS-CoV-2 Spike Protein Suitable for Multiple Applications for Current Variants of ConcernMahali S Morgan, Kexin Yan, Thuy T Le, et al.
Vaccines|May 9, 2020
Arthritogenic Alphavirus Vaccines: Serogrouping Versus Cross-Protection in Mouse ModelsWilson Nguyen, Eri Nakayama, Kexin Yan, et al.
Nature Communications|June 9, 2021
A versatile reverse genetics platform for SARS-CoV-2 and other positive-strand RNA virusesAlberto A Amarilla, Julian D J Sng, Rhys Parry, et al.
ACS Central Science|June 1, 2022
Synthetic Heparan Sulfate Mimetic Pixatimod (PG545) Potently Inhibits SARS-CoV-2 by Disrupting the Spike-ACE2 InteractionScott E Guimond, Courtney J Mycroft-West, Neha S Gandhi, et al.
Journal of Virology|April 25, 2025
Twelfth scientific biennial meeting of the Australasian Virology Society: AVS12 2024Ebony A Monson, Robson K Loterio, Justin A Roby, et al.
Cell|April 3, 2021
BET inhibition blocks inflammation-induced cardiac dysfunction and SARS-CoV-2 infectionRichard J Mills, Sean J Humphrey, Patrick R J Fortuna, et al.
Pageof 5